ABT
Abbott Laboratories
NYSE: ABT · HEALTHCARE · MEDICAL DEVICES
$90.79
-0.59% today
Updated 2026-04-30
Market cap
$158.70B
P/E ratio
25.58
P/S ratio
3.52x
EPS (TTM)
$3.57
Dividend yield
2.60%
52W range
$90 – $136
Volume
11.9M
Abbott Laboratories (ABT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $36.18B | $39.71B | $42.42B | $52.58B | $60.57B | $60.28B | $67.23B | $42.95B | $43.79B | $44.00B | $55.01B | $76.25B | $67.17B | $67.89B | $72.55B | $75.20B | $74.44B | $73.21B | $81.41B | — |
| Cash & equivalents | $521.19M | $2.46B | $4.11B | $8.81B | $7.32B | $6.81B | $10.80B | $3.48B | $4.06B | $5.00B | $18.62B | $9.41B | $3.84B | $3.86B | $6.84B | $9.80B | $9.88B | $6.90B | $7.62B | — |
| Current assets | $11.28B | $14.04B | $17.04B | $23.31B | $22.32B | $23.77B | $31.32B | $19.25B | $15.26B | $14.15B | $26.78B | $20.15B | $14.63B | $15.67B | $20.44B | $24.24B | $25.22B | $22.67B | $23.66B | — |
| Total liabilities | $22.12B | $21.94B | $24.94B | $29.52B | $36.99B | $35.75B | $40.42B | $17.69B | $19.64B | $19.92B | $31.95B | $45.15B | $36.45B | $36.59B | $39.55B | $39.17B | $37.53B | $34.39B | $33.51B | $641.00M |
| Current liabilities | $11.95B | $9.10B | $11.59B | $13.05B | $17.26B | $15.48B | $13.28B | $9.51B | $10.53B | $9.19B | $6.66B | $8.91B | $9.01B | $10.86B | $11.91B | $13.11B | $15.49B | $13.84B | $14.16B | $16.50B |
| Long-term debt | $7.01B | $9.49B | $8.71B | $11.27B | $12.52B | $12.04B | $18.09B | $3.39B | $3.41B | $5.87B | $20.68B | $27.21B | $19.36B | $16.66B | $18.53B | $17.30B | $14.52B | $13.60B | $12.63B | — |
| Shareholder equity | $14.05B | $17.78B | $17.48B | $23.14B | $22.68B | $24.44B | $26.72B | $25.17B | $21.53B | $21.21B | $20.54B | $30.90B | $30.52B | $31.09B | $32.78B | $35.80B | $36.69B | $38.60B | $47.66B | — |
| Retained earnings | $9.57B | $10.81B | $13.83B | $17.05B | $18.93B | $20.91B | $24.15B | $21.98B | $22.87B | $25.76B | $25.57B | $23.98B | $24.56B | $25.85B | $27.63B | $31.53B | $35.26B | $37.55B | $47.26B | — |
| Accounts receivable | $4.23B | $4.95B | $5.47B | $6.54B | $7.18B | $7.68B | $7.61B | $3.99B | $3.59B | $3.42B | $3.25B | $5.25B | $5.18B | $5.42B | $6.41B | $6.49B | $6.22B | $6.57B | $6.92B | — |
| Inventory | $2.81B | $2.95B | $2.78B | $3.26B | $3.19B | $3.28B | $3.79B | $2.69B | $2.64B | $2.60B | $2.43B | $3.60B | $3.80B | $4.32B | $5.01B | $5.16B | $6.17B | $6.57B | $6.19B | — |
| Goodwill | $9.45B | $10.13B | $9.99B | $13.20B | $15.93B | $15.71B | $15.77B | $9.77B | $10.07B | $9.64B | $7.68B | $24.02B | $23.25B | $23.20B | $23.74B | $23.23B | $22.80B | $23.68B | $23.11B | — |